Back to Search Start Over

NAUTIKA1: A Multicenter Phase II Study with a PD-L1+ Cohort of Patients Receiving Atezolizumab (Atezo) with Low-Dose Stereotactic Body Radiation Therapy (SBRT) as Neoadjuvant Therapy for Resectable Stage IB-III NSCLC

Authors :
S. Tian
D.E. Kozono
N. Ohri
S. Jolly
B.E. Johnson
J. Chaft
E.M. Toloza
B. Ding
C. Ngiam
K. Schulz
I. Bara
J.M. Lee
Source :
International Journal of Radiation Oncology*Biology*Physics. 114:e392-e393
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Details

ISSN :
03603016
Volume :
114
Database :
OpenAIRE
Journal :
International Journal of Radiation Oncology*Biology*Physics
Accession number :
edsair.doi...........ab148f5ea67946e21305adf944806cf3
Full Text :
https://doi.org/10.1016/j.ijrobp.2022.07.1550